Takeda Pharmaceutical (TAK) Non-Current Debt (2017 - 2026)
Takeda Pharmaceutical (TAK) posted Non-Current Debt of -$219 million for the quarter ended Jun 30, 2026, compared with -$121.16 million a year earlier.
Powered by 
Analysis
Takeda Pharmaceutical (TAK) Non-Current Debt (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Non-Current Debt at Takeda Pharmaceutical was -$620.13 million; for the year ended Mar 31, 2026, it was -$542.12 million.
- In prior years, Takeda Pharmaceutical's Non-Current Debt was -$22.9 million in the year ended Mar 31, 2025, -$128.75 million in the year ended Mar 31, 2024, $234.42 million in the year ended Mar 31, 2023 and -$441.86 million in the year ended Mar 31, 2022.
- Quarterly Non-Current Debt has run from a low of -$614.48 million in the quarter ended Mar 31, 2026 to a high of $299.19 million in the quarter ended Mar 31, 2023 over five years.
- According to Business Quant data, Non-Current Debt for the three prior quarters was -$614.48 million (quarter ended Mar 31, 2026), $130.4 million (quarter ended Dec 31, 2025) and $82.95 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 47.86 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 37.34 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 62.48 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 51.08 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 23.68 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 51.86 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 23.83 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 60.50 Bn |
| 10 | Takeda Pharmaceutical | 63.21 Bn | 39.57 Bn | 5.10 Bn | 27.30 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.30 Bn |
| Mar 31, 2026 | 27.34 Bn |
| Dec 31, 2025 | 27.30 Bn |
| Sep 30, 2025 | 29.28 Bn |
| Jun 30, 2025 | 28.61 Bn |
| Mar 31, 2025 | 26.51 Bn |
| Dec 31, 2024 | 29.97 Bn |
| Sep 30, 2024 | 31.01 Bn |
| Jun 30, 2024 | 31.38 Bn |
| Mar 31, 2024 | 29.56 Bn |
| Dec 31, 2023 | 30.36 Bn |
| Sep 30, 2023 | 29.49 Bn |
| Jun 30, 2023 | 29.91 Bn |
| Mar 31, 2023 | 30.35 Bn |
| Dec 31, 2022 | 29.45 Bn |
| Sep 30, 2022 | 28.86 Bn |
| Jun 30, 2022 | 31.63 Bn |
| Mar 31, 2022 | 33.94 Bn |
| Dec 31, 2021 | 36.78 Bn |
| Jun 30, 2021 | 39.64 Bn |
API Access
Takeda Pharmaceutical Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=TAK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "TAK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=TAK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();